Immuneering Corp. (IMRX)
6.16
-0.08
(-1.28%)
USD |
NASDAQ |
Dec 10, 16:00
6.06
-0.10
(-1.62%)
Pre-Market: 09:12
Immuneering Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Fortress Biotech, Inc. | 50.07% |
| BridgeBio Pharma, Inc. | -153.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.54% |
| Return on Assets | -68.97% |
| Return on Invested Capital | -74.71% |
| Return on Net Operating Assets | -535.9% |